News Announcement

Natco Pharma: Announcement under Regulation 30 (LODR)-Change in Management

1. Superannuation of Mr. S V V N Appa Rao Chief Financial Officer w.e.f. closure of business hours on 12th February 20262. Appointment of Mr. Amit Parekh as Chief Financial Officer of the Company w.e.f. 13th February 2026.3. Appointment of Mr. K Srinivasa Rao as Executive Vice President- Pharma Division w.e.f. 12th February 2026

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.